2023 NMSG 24TH Annual Scientific Meeting
Phase 1/2 Trial Evaluating AOC 1044 in Healthy Volunteers and Participants with DMD Mutations Amenable to Exon 44 Skipping (DMD44): EXPLORE44™️ Trial Design Phase 1/2 Study to Evaluate the Safety,...
View Article2023 World Muscle Society Congress
Topline Safety and Efficacy Data Analysis of Phase 1/2 Clinical Trial Evaluating AOC 1001 in Adults with Myotonic Dystrophy Type 1: MARINA™ AOC 1001 Demonstrates DMPK Reduction and Spliceopathy...
View Article2024 MDA Clinical and Scientific Conference
Initial results of the Phase 2 Open-Label Extension Study of AOC 1001 in Adults with Myotonic Dystrophy Type 1: MARINA-OLE™ AOC 1001-mediated Reduction of DMPK Leads to Increase in Functional MBNL...
View Article2024 International Myotonic Dystrophy Consortium Meeting
Effect of Long-Term Treatment of AOC 1001 in Adults with Myotonic Dystrophy Type 1: from MARINA® to MARINA-OLE™ AOC 1001-Mediated Reduction of DMPK Leads to Increase in Functional MBNL Levels,...
View Article2024 FSHD Society International Research Congress
Interim results from FORTITUDE™, a randomized Phase 1/2 trial evaluating AOC 1020 in adults with FSHD Increasing Diversity in Clinical Trial Participation: An Exploration of Clinical Trial Site...
View Article2024 NMSG 25TH Annual Scientific Meeting
Interim Results from FORTITUDE™, a Randomized Phase 1/2 Trial Evaluating AOC 1020 in Adults with FSHD The post 2024 NMSG 25TH Annual Scientific Meeting appeared first on Avidity Biosciences.
View Article2024 World Muscle Society Congress
Phase 3, Randomized, Global Study Assessing Efficacy and Safety of Del-desiran™ for the Treatment of Myotonic Dystrophy Type 1: HARBOR™ Trial Design The post 2024 World Muscle Society Congress appeared...
View ArticleAHA Scientific Sessions 2024
Novel Precision Cardiology Treatment for PRKAG2 Cardiomyopathy, a Subset of Patients with Wolff-Parkinson-White Syndrome The post AHA Scientific Sessions 2024 appeared first on Avidity Biosciences.
View ArticleStructure–Activity Relationship of Antibody–Oligonucleotide Conjugates:...
Journal of Medicinal ChemistryMichael Cochran, Danny Arias, Rob Burke, David Chu, Gulin Erdogan, Michael Hood, Philip Kovach, Hae Won Kwon, Yanling Chen, Michael Moon, Christopher D. Miller, Hanhua...
View ArticleStructure–Activity Relationship of Antibody–Oligonucleotide Conjugates:...
Journal of Medicinal ChemistryMichael Cochran, Isaac Marks, Tyler Albin, Danny Arias, Philip Kovach, Beatrice Darimont, Hanhua Huang, Usue Etxaniz, Hae Won Kwon, Yunyu Shi, Matthew Diaz, Olecya Tyaglo,...
View Article